Agenus · 7 hours ago
Senior Manager, Corporate Development
Lexington, MA
Full-time
Onsite
Senior Level, Lead/Staff
$120K/yr - $160K/yr
8+ years expAgenus is a company dedicated to discovering and developing therapies that harness the immune system to treat cancer. The Senior Manager, Corporate Development will lead and support projects across Business Development, Strategic Finance, and Investor Relations, coordinating efforts across various cross-functional teams.
BiotechnologyMedicalMedical DeviceTherapeutics
Hiring Manager
Jeniece Waite
Responsibilities
Recurring investor engagement
Coordination of, and potential participation in, annual Healthcare Conferences
Sell-side analyst engagement
Coordination of, and potential participation in, other recurring activities, including monthly retail shareholder calls, quarterly earnings announcements, non-deal road shows, R&D and Investor days at Medical congresses, and the annual shareholder meeting
Management and refinement of Agenus all-company multi year pro forma financial model
Long Range Development Planning
Same broad strategic efforts for Agenus, MiNK, and SaponiQx
CMC partnership efforts
Maintenance and continued management of active royalty agreements and strategic partnerships
Continued engagement with prospective pharma partners for BOT/BAL
Potential leadership of/participation in integration needs post-pharma partnership
Continued engagement with prospective BOT/BAL regional partnerships (MENA, LATAM, APAC, E.Europe/CIS)
AGEN2373 go-forward BD needs
Annual key meetings (JPM, ASCO, BIO)
Maintenance of interaction tracking tools (Monday.com, Excel)
SaponiQx BD interactions (vaccine manufacturers, pharma service providers, supply/materials resellers)
Planning and potential leadership of additional active out licensing activities for other assets
Qualification
Required
Bachelor's degree required; advanced degree (MBA, MS, or related) preferred
8–10 years of relevant experience in life sciences, biotech, pharma, consulting, investment banking, or corporate/business development roles
Solid understanding of the biopharma landscape, including drug development stages, regulatory considerations, and commercial drivers
Strong financial and analytical skills with experience building and managing financial models and development plans
Demonstrated ability to manage complex, cross-functional projects with attention to detail and timely delivery
Excellent communication and presentation skills, with comfort engaging investors, analysts, and external partners in both written and verbal settings
Strong organizational skills with the ability to manage multiple priorities and deadlines in a fast-paced environment
Proficiency in Excel, PowerPoint, and collaboration/project management tools (e.g., Monday.com)
Collaborative mindset with the ability to work effectively across Clinical, R&D, Commercial, Legal, Regulatory, and CMC teams
Preferred
Prior experience in investor relations, corporate strategy, or business development within healthcare/biotech strongly preferred
Benefits
Medical, Dental & Vision Coverage – Competitive options for both US & UK employees
Flexible Spending Accounts – For healthcare and dependent care expenses (US)
Flexible Vacation Plan – We believe time away leads to better thinking and innovation.
Care.com Memberships – Support for family care (US)
Education Assistance Program – Invest in your learning and development (US)
401(k) Match
Employee Stock Purchase Plan
Employee Assistance Program (EAP) – Resources for mental health, well-being, and life support
Reward & Recognition Program – Celebrate contributions that move the mission forward
Company
Agenus
Agenus develops and commercializes immunotherapies and vaccines for cancer and infectious diseases.
201-500 employees
Funding
Current Stage
Public CompanyTotal Funding
$382.14MKey Investors
Zynext VenturesLigand Pharmaceuticals
2025-06-03Post Ipo Equity· $16M
2024-11-27Post Ipo Debt· $20M
2024-05-07Post Ipo Debt· $75M
Leadership Team
Robin Taylor
Chief Commercial Officer
Recent News
2025-12-24
Company data provided by crunchbase